Neil Herskowitz, Director at AVENUE THERAPEUTICS, INC. (ATXI), bought 8,850 shares at $5.91 ($52K) on 2019-02-04, disclosed to the SEC on 2019-02-06.
Open-market purchase of $52k ATXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.91 | 7,000 | $41K | 79.5% |
| 2 | $5.77 | 1,850 | $11K | 20.5% |
| Total | $5.88 avg | 8,850 | $52K | 100% |
| Filing → |
| ATXI | BUY | 2021-05-07 | $10K | — | Filing → |
| ATXI | BUY | 2020-03-02 | $21K | — | Filing → |
| ATXI | BUY | 2020-02-25 | $93K | — | Filing → |